MoneyWorks4Me

The company witnessed a 16.70% growth in the revenue at Rs. 825.60 millions for the quarter ended March 2023 as compared to Rs. 707.48 millions during the year-ago period.A slim rise of 21.91% was recorded in the Net profit for the quarter ended March 2023 to Rs. 174.97  millions  From Rs. 143.52 millions.The company reported a good operating profit of 260.92 millions compared to 205.52 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 825.60 707.48 16.70 3115.29 2727.98 14.20 3115.29 2727.98 14.20
Other Income 28.10 51.69 -45.64 98.08 90.80 8.02 98.08 90.80 8.02
PBIDT 260.92 205.52 26.96 846.96 817.28 3.63 846.96 817.28 3.63
Interest 0.57 0.52 9.62 1.35 0.95 42.11 1.35 0.95 42.11
PBDT 260.35 205.00 27.00 845.61 816.33 3.59 845.61 816.33 3.59
Depreciation 27.57 25.34 8.80 102.83 95.61 7.55 102.83 95.61 7.55
PBT 232.78 179.66 29.57 742.78 720.72 3.06 742.78 720.72 3.06
TAX 57.81 36.14 59.96 187.51 175.61 6.78 187.51 175.61 6.78
Deferred Tax 5.52 -3.52 -256.82 4.97 -4.56 -208.99 4.97 -4.56 -208.99
PAT 174.97 143.52 21.91 555.27 545.11 1.86 555.27 545.11 1.86
Equity 223.65 223.60 0.02 223.65 223.60 0.02 223.65 223.60 0.02
PBIDTM(%) 31.60 29.05 8.79 27.19 29.96 -9.25 27.19 29.96 -9.25
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..